Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#1903 Hypoglycemias Appearing in a Patient Suffering from Poorly Differentiated Neuroendocrine Tumor for Three Years.

Introduction: Insulinomas are the most common functional PNENs and they have a weak malignant potential (<10%)

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Deslé M, Dermine A, Grandjean M, Seront E, Lejeune S,

Keywords: neuroendocrine neoplasm, insulinoma, hypoglycemia,

#1741 Complete Remission of Hepatic Metastasis after Total Gastrectomy for a Gastric Carcinoid Tumor Type 1: A Case Report

Introduction: A 58-year-old woman was referred to our hospital for hepatic lesions and thickening of the walls of the stomach detected by abdominal CT scan. An upper GI endoscopy showed a lesion of the body of the stomach and the histopathologic exam documented a well differentiated NET. 68Ga-DOTATOC PET showed pathologic uptake in the stomach and in the liver (3 lesions). Circulating chromogranin A and gastrin were 596 ng/ml and 2283 pg/ml respectively

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Smiroldo V

Authors: Smiroldo V, Carnaghi C, Tresoldi A, Lania A, Bonifacio C,

Keywords: gastric, NET, complete remission, gastrin,

#1506 Somatostatin Analogs and mTOR Inhibitors as Radioprotectors or Radiosensitizers in Neuroendocrine Tumor Cells

Introduction: PRRT can deliver radiation doses of up to 250 Gy to the tumors. Nevertheless, complete remission is extremely rare, compared to similar radiotherapies for thyroid cancer and non-Hodgkin lymphoma.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Exner S, Erdmann S, Wiedenmann B, Prasad V, Grötzinger C,

Keywords: PRRT,

#190 Complete Remission in a Patient with Metastatic Type 1 Gastric Carcinoid (GCA1) Treated with a Long-acting Somatostatin Analogue

Introduction: Surgery is the treatment of choice for invasive and metastatic GCA1. Somatostatin analogues have been successfully used in GCA1 patients without signs of malignancy.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Fraenkel M, Barak D, Appelbaum L, Krausz Y, Gross D,

Keywords: metastatic type one gastric carcinoid, somatostatin analogue,